Characterisation of biomarkers of intestinal barrier function in response to a high fat/high carbohydrate meal and corticotropin releasing hormone

Copyright: © 2024 Mogilevski et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited..

BACKGROUND: Variation of circulating concentrations of putative biomarkers of intestinal barrier function over the day and after acute physiological interventions are poorly documented on humans. This study aimed to examine the stability and pharmacokinetics of changes in plasma concentrations of intestinal Fatty-acid -binding -protein (IFABP), Lipopolysaccharide-binging-protein (LBP), soluble CD14, and Syndecan-1 after acute stress and high fat-high-carbohydrate meal.

METHODS: In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. Participants were allowed low caloric food. Markers of intestinal barrier function were measured at set timed intervals from 30 minutes before to 24 hours after interventions.

RESULTS: 10 participants (50% female) completed all three arms of the study. IFABP decreased by median 3.6 (IQR 1.4-10)% from -30 minutes to zero time (p = 0.001) and further reduced by 25 (20-52)% at 24 hours (p = 0.01) on the low caloric diet, but did not change in response to the meal. Syndecan-1, LBP and sCD14 were stable over a 24-hour period and not affected acutely by food intake. LBP levels 2 hours after CRH reduced by 0.61 (-0.95 to 0.05) μg/ml compared with 0.16 (-0.3 to 0.5) μg/ml post placebo injection (p = 0.05), but other markers did not change.

CONCLUSION: Concentrations of IFABP, but not other markers, are unstable over 24 hours and should be measured fasting. A HFHC meal does not change intestinal permeability. Transient reduction of LPB after CRH confirms acute barrier dysfunction during stress.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:19

Enthalten in:

PloS one - 19(2024), 2 vom: 03., Seite e0294918

Sprache:

Englisch

Beteiligte Personen:

Mogilevski, Tamara [VerfasserIn]
Rosella, Sam [VerfasserIn]
Nguyen, Anke [VerfasserIn]
Fitzpatrick, Jessica [VerfasserIn]
Parker, Francis [VerfasserIn]
Halmos, Emma P [VerfasserIn]
Gibson, Peter R [VerfasserIn]

Links:

Volltext

Themen:

9015-71-8
Biomarkers
Corticotropin-Releasing Hormone
Journal Article
Lipopolysaccharides
Randomized Controlled Trial
Syndecan-1

Anmerkungen:

Date Completed 28.02.2024

Date Revised 29.02.2024

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.1371/journal.pone.0294918

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM368980154